Decentralized Clinical Trials Market Seen Reaching $38.3B by 2035, TMO Positioned
What happened
A Healthcare Foresights market analysis projects the global decentralized clinical trials sector will reach $38.3 billion by 2035, expanding at a 14.5% compound annual growth rate. Thermo Fisher Scientific is identified among the leading participants in this segment. Decentralized trial models shift patient participation away from traditional clinical sites, relying on remote monitoring tools, digital data collection, and distributed logistics — all areas where TMO has established service offerings within its contract research organization operations.
The QL Read
TMO's composite signal sits at 38/100 (Sell) against a severely deteriorated tape — only 21.2% of issues advancing. A long-dated market-size projection adds little near-term catalyst weight under these conditions.